Drug intelligence / Profile preview

BCG SII

Development stage
Unknown
Lead developer
Serum Institute of India
Modality
Vaccines & Immunotherapeutics
Administration
Intradermal, Intravesical Instillation
01

Overview

BCG SII is a live attenuated vaccine manufactured by the Serum Institute of India (SII). It is primarily used for the prevention of tuberculosis (TB), especially in infants and young children, by stimulating the body's immune response to fight *Mycobacterium tuberculosis*. Additionally, it is utilized as an immunotherapy for superficial bladder cancer, specifically non-muscle invasive bladder cancer (NMIBC), including carcinoma in situ (CIS) and papillary tumors (stage Ta or T1). In this context, it induces a local, chronic inflammatory response within the bladder, leading to the destruction of superficial tumor cells through immune cell infiltration and direct cytotoxic effects.

Brand names
Onco-BCG
Other names
SII BCG VaccineSII-ONCO-BCGBacillus Calmette-Guerin Vaccine
02

Targets

CD4 (T lymphocyte surface antigen)

Beyond the preview

Go deeper on BCG SII.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on BCG SII.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call